JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1574.5
  • 0.00.00%
20min DelayTrading Dec 11 15:30 JST
2.85TMarket Cap166.26P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Operating cash flow (Indirect Method)
Cash from operating activities
159.59%49.42B
-46.99%210.59B
-31.05%87.51B
-42.38%54.9B
-47.46%49.14B
-76.65%19.04B
32.62%397.25B
123.26%126.91B
20.24%95.28B
-17.31%93.53B
Net profit before non-cash adjustment
7.78%50.5B
-81.14%24.97B
-1.64%-48.66B
-71.03%17.31B
-89.34%9.47B
47.89%46.85B
-15.63%132.36B
-355.28%-47.88B
-23.70%59.76B
66.75%88.8B
Total adjustment of non-cash items
249.45%47.99B
-5.87%272.14B
-10.33%132.14B
18.22%63.76B
706.05%62.5B
-82.84%13.73B
111.49%289.09B
137.34%147.37B
945.21%53.93B
-81.35%7.75B
-Depreciation and amortization
116.26%50.27B
49.27%157.84B
111.34%48.64B
104.30%46.98B
70.53%38.97B
-36.96%23.24B
32.70%105.74B
9.18%23.02B
6.86%23B
20.67%22.85B
-Reversal of impairment losses recognized in profit and loss
-95.06%520M
-6.59%78.93B
8.12%65.16B
-60.86%575M
263.71%2.67B
-52.19%10.54B
12.89%84.5B
25.20%60.26B
121.23%1.47B
36,550.00%733M
-Other non-cash items
86.06%-2.8B
-64.23%35.37B
-71.38%18.34B
-45.01%16.2B
231.80%20.87B
-194.84%-20.05B
654.16%98.86B
999.58%64.09B
203.15%29.47B
-169.91%-15.83B
Changes in working capital
-18.11%-49.07B
-257.38%-86.52B
-85.31%4.03B
-42.17%-26.17B
-655.33%-22.83B
-37.57%-41.55B
-506.46%-24.21B
420.28%27.42B
-351.94%-18.41B
-116.54%-3.02B
-Change in receivables
-419.87%-26.79B
-1,053.80%-55.95B
-170.98%-24.04B
-3.54%-25.61B
-629.79%-14.67B
150.00%8.37B
39.40%-4.85B
248.93%33.87B
-455.54%-24.74B
-58.90%2.77B
-Change in inventory
104.71%790M
-747.25%-60.04B
-58.45%-15.42B
-730.77%-15.99B
-196.65%-11.87B
-507.39%-16.76B
-129.45%-7.09B
-243.23%-9.73B
37.85%2.54B
-155.81%-4B
-Change in payables
30.42%-23.08B
340.07%29.47B
1,221.51%43.49B
306.75%15.43B
307.15%3.71B
-88.79%-33.17B
-21.51%-12.27B
129.30%3.29B
-61.76%3.79B
-140.97%-1.79B
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid
-438.40%-36.82B
45.15%-38.11B
-37.18%-15.53B
66.78%-7.63B
-223.77%-8.12B
79.08%-6.84B
-65.06%-69.48B
-37.05%-11.32B
-135.10%-22.97B
81.85%-2.51B
Other operating cash inflow (outflow)
0
0
0
0
0
0
0
1M
-1M
0.00%-1M
Operating cash flow
3.30%12.6B
-47.38%172.48B
-37.73%71.98B
-34.63%47.27B
-54.93%41.02B
-75.02%12.2B
27.32%327.77B
137.92%115.59B
4.09%72.32B
-8.34%91.03B
Investing cash flow
Net PPE purchase and sale
-39.11%-14B
-4.43%-38.06B
6.39%-10.53B
34.43%-7.47B
-79.69%-9.99B
-22.19%-10.06B
-18.55%-36.44B
-7.12%-11.25B
-315.08%-11.4B
31.70%-5.56B
Net intangibles purchase and sale
-93.45%-9.63B
35.56%-33.44B
44.30%-9.4B
19.58%-7.48B
26.99%-11.59B
49.47%-4.98B
-142.15%-51.89B
-153.79%-16.87B
-159.61%-9.3B
19.95%-15.87B
Net business purchase and sale
----
---784.97B
---190M
---20.61B
----
----
--0
--0
--0
----
Net investment product transactions
----
--0
--0
----
----
----
126.40%12.62B
-90.67%456M
-73.77%64M
----
Interest received (cash flow from investment activities)
15.68%1.64B
94.16%8.85B
4.08%2.58B
56.69%1.66B
334.69%3.2B
393.38%1.42B
536.59%4.56B
1,381.44%2.47B
313.23%1.06B
368.15%735M
Net changes in other investments
-1,410.04%-17.36B
113.60%1.82B
-287.31%-4.62B
69.66%-2.29B
206.84%7.4B
198.73%1.33B
15.85%-13.35B
190.46%2.47B
-45.56%-7.55B
5.04%-6.93B
Investing cash flow
-219.91%-39.35B
-900.95%-845.8B
2.47%-22.16B
-33.44%-36.19B
-4,895.84%-775.15B
35.75%-12.3B
-35.39%-84.5B
-53.23%-22.72B
-432.45%-27.12B
55.23%-15.52B
Financing cash flow
Net issuance payments of debt
-72.16%65.14B
5,241.55%771.23B
186.23%43.12B
-134.46%-17.23B
1,804.48%511.35B
1,460.00%234B
75.00%-15B
-150.00%-50B
--50B
25.00%-30B
Net common stock issuance
35.17%-6.96B
82.27%-10.74B
100.00%-1M
0.00%-2M
---1M
-1.69%-10.73B
-19.40%-60.56B
0.00%-50B
-100.00%-2M
--0
Increase or decrease of lease financing
12.30%-2.88B
19.70%-13.25B
7.64%-3.29B
20.17%-3.26B
17.97%-3.42B
29.98%-3.28B
7.41%-16.5B
17.98%-3.56B
7.04%-4.08B
9.77%-4.16B
Cash dividends paid
-16.43%-62.76B
-16.24%-116.65B
--0
-14.76%-62.75B
--0
-18.01%-53.9B
-17.74%-100.36B
--0
-18.04%-54.68B
--0
Net other fund-raising expenses
-328.43%-4.46B
-414.11%-16.54B
-846.38%-8.9B
-307.75%-3.79B
-322.52%-2.81B
-52.64%-1.04B
-27.15%-3.22B
-36.23%-940M
-50.81%-929M
-12.88%-666M
Financing cash flow
-107.22%-11.92B
413.90%614.06B
129.60%30.93B
-798.18%-87.03B
1,550.27%505.12B
454.15%165.04B
9.56%-195.62B
-39.27%-104.5B
81.12%-9.69B
22.95%-34.83B
Net cash flow
Beginning cash position
-10.92%335.69B
19.26%376.84B
-33.48%253.98B
-7.50%333.99B
79.38%561.49B
19.26%376.84B
-3.11%315.99B
9.02%381.82B
13.44%361.07B
3.67%313.01B
Current changes in cash
-123.44%-38.67B
-224.40%-59.27B
794.38%80.75B
-313.88%-75.94B
-662.97%-229.02B
1,075.16%164.94B
324.03%47.64B
71.83%-11.63B
34.99%35.51B
109.29%40.68B
Effect of exchange rate changes
-70.02%5.91B
37.12%18.11B
-85.62%957M
72.41%-4.07B
-79.39%1.52B
41.37%19.71B
18.74%13.21B
-5.62%6.65B
-362.94%-14.76B
340.94%7.38B
Cash adjustments other than cash changes
--1M
--1M
--2M
----
----
----
----
----
----
----
End cash Position
-46.05%302.93B
-10.92%335.69B
-10.92%335.69B
-33.48%253.98B
-7.50%333.99B
79.38%561.49B
19.26%376.84B
19.26%376.84B
9.02%381.82B
13.44%361.07B
Free cash flow
-186.63%-11.94B
-62.39%89.98B
-40.49%52.06B
-37.96%32B
-85.51%10.08B
-113.62%-4.17B
32.17%239.23B
179.35%87.47B
-11.33%51.58B
-2.44%69.6B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Operating cash flow (Indirect Method)
Cash from operating activities 159.59%49.42B-46.99%210.59B-31.05%87.51B-42.38%54.9B-47.46%49.14B-76.65%19.04B32.62%397.25B123.26%126.91B20.24%95.28B-17.31%93.53B
Net profit before non-cash adjustment 7.78%50.5B-81.14%24.97B-1.64%-48.66B-71.03%17.31B-89.34%9.47B47.89%46.85B-15.63%132.36B-355.28%-47.88B-23.70%59.76B66.75%88.8B
Total adjustment of non-cash items 249.45%47.99B-5.87%272.14B-10.33%132.14B18.22%63.76B706.05%62.5B-82.84%13.73B111.49%289.09B137.34%147.37B945.21%53.93B-81.35%7.75B
-Depreciation and amortization 116.26%50.27B49.27%157.84B111.34%48.64B104.30%46.98B70.53%38.97B-36.96%23.24B32.70%105.74B9.18%23.02B6.86%23B20.67%22.85B
-Reversal of impairment losses recognized in profit and loss -95.06%520M-6.59%78.93B8.12%65.16B-60.86%575M263.71%2.67B-52.19%10.54B12.89%84.5B25.20%60.26B121.23%1.47B36,550.00%733M
-Other non-cash items 86.06%-2.8B-64.23%35.37B-71.38%18.34B-45.01%16.2B231.80%20.87B-194.84%-20.05B654.16%98.86B999.58%64.09B203.15%29.47B-169.91%-15.83B
Changes in working capital -18.11%-49.07B-257.38%-86.52B-85.31%4.03B-42.17%-26.17B-655.33%-22.83B-37.57%-41.55B-506.46%-24.21B420.28%27.42B-351.94%-18.41B-116.54%-3.02B
-Change in receivables -419.87%-26.79B-1,053.80%-55.95B-170.98%-24.04B-3.54%-25.61B-629.79%-14.67B150.00%8.37B39.40%-4.85B248.93%33.87B-455.54%-24.74B-58.90%2.77B
-Change in inventory 104.71%790M-747.25%-60.04B-58.45%-15.42B-730.77%-15.99B-196.65%-11.87B-507.39%-16.76B-129.45%-7.09B-243.23%-9.73B37.85%2.54B-155.81%-4B
-Change in payables 30.42%-23.08B340.07%29.47B1,221.51%43.49B306.75%15.43B307.15%3.71B-88.79%-33.17B-21.51%-12.27B129.30%3.29B-61.76%3.79B-140.97%-1.79B
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid -438.40%-36.82B45.15%-38.11B-37.18%-15.53B66.78%-7.63B-223.77%-8.12B79.08%-6.84B-65.06%-69.48B-37.05%-11.32B-135.10%-22.97B81.85%-2.51B
Other operating cash inflow (outflow) 00000001M-1M0.00%-1M
Operating cash flow 3.30%12.6B-47.38%172.48B-37.73%71.98B-34.63%47.27B-54.93%41.02B-75.02%12.2B27.32%327.77B137.92%115.59B4.09%72.32B-8.34%91.03B
Investing cash flow
Net PPE purchase and sale -39.11%-14B-4.43%-38.06B6.39%-10.53B34.43%-7.47B-79.69%-9.99B-22.19%-10.06B-18.55%-36.44B-7.12%-11.25B-315.08%-11.4B31.70%-5.56B
Net intangibles purchase and sale -93.45%-9.63B35.56%-33.44B44.30%-9.4B19.58%-7.48B26.99%-11.59B49.47%-4.98B-142.15%-51.89B-153.79%-16.87B-159.61%-9.3B19.95%-15.87B
Net business purchase and sale -------784.97B---190M---20.61B----------0--0--0----
Net investment product transactions ------0--0------------126.40%12.62B-90.67%456M-73.77%64M----
Interest received (cash flow from investment activities) 15.68%1.64B94.16%8.85B4.08%2.58B56.69%1.66B334.69%3.2B393.38%1.42B536.59%4.56B1,381.44%2.47B313.23%1.06B368.15%735M
Net changes in other investments -1,410.04%-17.36B113.60%1.82B-287.31%-4.62B69.66%-2.29B206.84%7.4B198.73%1.33B15.85%-13.35B190.46%2.47B-45.56%-7.55B5.04%-6.93B
Investing cash flow -219.91%-39.35B-900.95%-845.8B2.47%-22.16B-33.44%-36.19B-4,895.84%-775.15B35.75%-12.3B-35.39%-84.5B-53.23%-22.72B-432.45%-27.12B55.23%-15.52B
Financing cash flow
Net issuance payments of debt -72.16%65.14B5,241.55%771.23B186.23%43.12B-134.46%-17.23B1,804.48%511.35B1,460.00%234B75.00%-15B-150.00%-50B--50B25.00%-30B
Net common stock issuance 35.17%-6.96B82.27%-10.74B100.00%-1M0.00%-2M---1M-1.69%-10.73B-19.40%-60.56B0.00%-50B-100.00%-2M--0
Increase or decrease of lease financing 12.30%-2.88B19.70%-13.25B7.64%-3.29B20.17%-3.26B17.97%-3.42B29.98%-3.28B7.41%-16.5B17.98%-3.56B7.04%-4.08B9.77%-4.16B
Cash dividends paid -16.43%-62.76B-16.24%-116.65B--0-14.76%-62.75B--0-18.01%-53.9B-17.74%-100.36B--0-18.04%-54.68B--0
Net other fund-raising expenses -328.43%-4.46B-414.11%-16.54B-846.38%-8.9B-307.75%-3.79B-322.52%-2.81B-52.64%-1.04B-27.15%-3.22B-36.23%-940M-50.81%-929M-12.88%-666M
Financing cash flow -107.22%-11.92B413.90%614.06B129.60%30.93B-798.18%-87.03B1,550.27%505.12B454.15%165.04B9.56%-195.62B-39.27%-104.5B81.12%-9.69B22.95%-34.83B
Net cash flow
Beginning cash position -10.92%335.69B19.26%376.84B-33.48%253.98B-7.50%333.99B79.38%561.49B19.26%376.84B-3.11%315.99B9.02%381.82B13.44%361.07B3.67%313.01B
Current changes in cash -123.44%-38.67B-224.40%-59.27B794.38%80.75B-313.88%-75.94B-662.97%-229.02B1,075.16%164.94B324.03%47.64B71.83%-11.63B34.99%35.51B109.29%40.68B
Effect of exchange rate changes -70.02%5.91B37.12%18.11B-85.62%957M72.41%-4.07B-79.39%1.52B41.37%19.71B18.74%13.21B-5.62%6.65B-362.94%-14.76B340.94%7.38B
Cash adjustments other than cash changes --1M--1M--2M----------------------------
End cash Position -46.05%302.93B-10.92%335.69B-10.92%335.69B-33.48%253.98B-7.50%333.99B79.38%561.49B19.26%376.84B19.26%376.84B9.02%381.82B13.44%361.07B
Free cash flow -186.63%-11.94B-62.39%89.98B-40.49%52.06B-37.96%32B-85.51%10.08B-113.62%-4.17B32.17%239.23B179.35%87.47B-11.33%51.58B-2.44%69.6B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Gumi
3903
461 +18.81%
Waqoo
4937
1599 +14.21%
Land
8918
9 +12.50%
Chiome Bioscience
4583
226 +12.44%
Pluszero
5132
2509 +10.38%

See the daily top gainer.